Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Psychemedics Corporation

    NASDAQ: PMD · Real-Time Price · USD
    2.67
    0.00 (0.00%)
    At close: Jan 16, 2025, 9:00 PM
    0.00%
    Bid 2.37
    Market Cap 15.74M
    Revenue (ttm) 20.26M
    Net Income (ttm) -3M
    EPS (ttm) -0.51
    PE Ratio (ttm) -5.235294117647059
    Forward PE n/a
    Analyst n/a
    Ask 2.5
    Volume 112,269
    Avg. Volume (20D) 42,860
    Open 2.60
    Previous Close 2.67
    Day's Range 2.60 - 2.67
    52-Week Range 1.11 - 3.93
    Beta 0.67

    About PMD

    undefined

    [Read more]
    Industry n/a
    Sector n/a
    IPO Date n/a
    Employees NaN
    Stock Exchange n/a
    Ticker Symbol PMD
    Website n/a
    Full Company Profile

    Why Price Moved

    Why Price Moved is a one-sentence explanation of why a stock is moving higher or down. By removing noise and collecting signals from news, press releases and SEC filings, we can pinpoint the trigger for price movements.
    8 months ago
    Psychemedics shares are trading higher after the c... Unlock content with Pro Subscription
    news image

    3 years ago · seekingalpha.com

    Psychemedics: 21% Sales Growth But Net Loss, Takeover Possibility, Covid Recovery Play

    21% YoY revenue growth in Q4, gross margins surge 1,000 bps YoY. EPS loss of $0.29 on higher legal costs and a one-time expense.

    news image

    3 years ago · seekingalpha.com

    Small And Microcap Newsletter: DHT Holdings Financials Give It Time Until The Next Tanker Bull Market

    In this week's newsletter, we look at a company in the middle of monetizing its major asset to see what is left after the deal closes. We also review a shipping company that has built a strong margin ...

    news image

    3 years ago · seekingalpha.com

    Psychemedics: Q3 Revenues +29%, Margins Surge, Possible Corporate Actions Including Dividend

    29% YoY revenue growth in Q3, margins surge.

    news image

    3 years ago · seekingalpha.com

    Psychemedics: Market Leader, 8% FCF Yield, Possible Takeover Target

    Market-leading drug testing company, 30 years history, drug abuse increasing in the US. 13x P/E, 8% FCF yield on “normal” 2023 estimates.

    news image

    3 years ago · businesswire.com

    Montana Advisors Writes Open Letter to Psychemedics

    MIAMI--(BUSINESS WIRE)---- $PMD--Montana Advisors issues open letter to Psychemedics CEO (Nasdaq: PMD): Dear Kubacki: It was a pleasure speaking with you two months ago via Zoom. I appreciate the time...

    Add to Watchlist